Related Experiment Videos

Amphotericin B inhibits the serum-induced expression of tissue transglutaminase in murine peritoneal macrophages

Insights

Amphotericin B (AmpB) inhibits the production of tissue transglutaminase (tTG) in mouse macrophages by blocking serum retinoid uptake. This inhibition is dose-dependent and reversible, impacting enzyme synthesis.

Area of Science:

  • Cell Biology
  • Enzymology
  • Pharmacology

Background:

  • Serum-containing media rapidly induce tissue transglutaminase (tTG) in mouse peritoneal macrophages (PM).
  • Understanding the regulation of tTG expression is crucial for cellular processes.

Purpose of the Study:

  • To investigate the effect of amphotericin B (AmpB) on serum-induced tissue transglutaminase (tTG) expression in PM.
  • To elucidate the mechanism behind AmpB-mediated inhibition of tTG synthesis.

Main Methods:

  • Culture of mouse resident peritoneal macrophages (PM).
  • Treatment with amphotericin B (AmpB) at varying doses and durations.
  • Measurement of tissue transglutaminase (tTG) expression and accumulation.

Main Results:

  • AmpB significantly inhibited serum-induced tTG expression and accumulation in PM.
  • The inhibition was dose-dependent, with complete suppression at 1.5 µg/ml AmpB.
  • AmpB's effect was specific to enzyme synthesis and reversible, with recovery time dependent on exposure.

Conclusions:

  • AmpB inhibits tTG synthesis in PM by interfering with the uptake of serum retinoids.
  • This mechanism highlights a novel regulatory pathway for tTG expression.
  • AmpB's action provides insights into retinoid metabolism and its impact on enzyme production.

Related Concept Videos